课题基金 / 基金详情

Inductioin and activation of p53 tumor suppressor protein by Cdt in HPV-related cancer cells

Inductioin and activation of p53 tumor suppressor protein by Cdt in HPV-related cancer cells
Cdt 在 HPV 相关癌细胞中诱导和激活 p53 肿瘤抑制蛋白
批准号:
13671962
负责人:
YAMATO Kenji
金额:
$1.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
关键词:

项目摘要

项目成果

YAMATO Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cytolethal distending toxin (Cdt) from Actinobacillus actinomycetemcomitans has been shown to induce cell cycle arrest in the G2 phase as well as cell death in mammalian cells. However, the precise mechanism by which the toxin induces these effects remains unknown. Human papillomavirus-16 (HPV-16) and HPV-18 are considered as causative agents of most human rectogenital cancers and part of oropharyngeal cancers. The E7 viral oncoprotein inactivates the retinoblastoma-related gene-product (Rb) and the E6 oncoprotein inhibits the p53 tumor suppressor protein by promoting its degradation.We have found that Cdt caused accumulation of p53 during the induction of G2 arrest and cell death in HPV-18 positive HeLa cells. HS-72 mouse hybridoma cells expressing wild-type p53 were stably transfected with HPV-16 E6/E7. Using E6/E7-expressing HS-72 cells, we demonstrated that these cells were also sensitive to Cdt-mediated G2 arrst and cell death. To explore the molecular mechanism of p53 accumulation, we established the the siRNA system in HPV-positive cancer cell lines (HeLa, SiHa).Using lamin A/C siRNA which had been reported to exhibit a strong RNAi activity, we maximize the induction rate of siRHA into these cells. He found that HeLa cells and SiHa cells can be introduced with siRNA with a extremely high efficiency (more than 90%). We also found synthesized HPV-16 E6 and E7 siRNAs down-regulated the expression E6 and E7 mRHA by 70% and 80%, respectively. These results showed that SiHa cells were highly susceptible to siRNA. We are now planning to study if either ATM, ATR, Chkl, Chk2, DNA-PK or ARF is involved in the Cdt-induced p53 accumulation using the siRNA method.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Ito, K., et al.: "Caffeine induces G2/M arrest and apoptosis via novel p53-dependent pathway in NB4 promyelocytic leukemia cells"J. Cell Physiol. (in press).
Ito, K. 等人:“咖啡因在 NB4 早幼粒细胞白血病细胞中通过新型 p53 依赖性途径诱导 G2/M 期停滞和细胞凋亡”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ito, K., et al.: "Caffeine induces G2/M arrest and apoptosis via novel p53-dependent pathway in NB4 promyelocytic leukemia cells"J. Cell Physiol.. (in press).
Ito, K. 等人:“咖啡因在 NB4 早幼粒细胞白血病细胞中通过新型 p53 依赖性途径诱导 G2/M 期停滞和细胞凋亡”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fukuchi, Y. et al.: "Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML"Oncogene. 20. 704-713 (2001)
Fukuchi, Y. 等人:“Mcl-1 是一种早期诱导分子,调节激活素 A 诱导的细胞凋亡和 CML 分化”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Organotypic epithelial raft cultures as HPV-related cancer models for evaluating siRNA and its delivery system
    siRNA-mediated highly potent and specific RNAi in human culturedcells and its signals
    • 批准号:
      19592169
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      YAMATO Kenji
    • 依托单位:
    In vitro and in vivo growth suppression of HPV-related cancer cells by siRNA targeting E6 oncogene
    • 批准号:
      15591991
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      YAMATO Kenji
    • 依托单位:
    Anti-myeloma activity of members of the TGF-β family with induction of growth arrest and apoptosis^*
    • 批准号:
      12557157
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.31万
    • 财政年份:
      2000
    • 负责人:
      YAMATO Kenji
    • 依托单位:
    国内基金
    海外基金
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究